pubmed-article:10637388 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10637388 | lifeskim:mentions | umls-concept:C0175649 | lld:lifeskim |
pubmed-article:10637388 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:10637388 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
pubmed-article:10637388 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:10637388 | pubmed:dateCreated | 2000-2-10 | lld:pubmed |
pubmed-article:10637388 | pubmed:abstractText | Two hundred and two patients (97 female and 105 male; mean age: 45. 5+/-9 years) received CarboMedics bileaflet valves during a period of eight years. Ninety-one patients received mitral, 72 aortic and 39 aortic+mitral valve prosthesis. Tricuspid plasty and coronary artery bypass surgery were the concomitant operations in 17 and 12 patients, respectively. The mean follow-up period was 24.7 months and the ratio was 91%. Overall operative mortality was 3.96% (8 patients); 2.78% for aortic valve replacement (AVR), 3.29% for mitral valve replacement (MVR) and 7.7% for double valve replacement (DVR). The late mortality rate was 2.89% for AVR, 2.2% for MVR and 8. 3% for DVR. The main cause of mortality was low cardiac output. The overall survival rate was 91.5% in 2 years. The actuarial freedom from thromboembolism in 2 years was 97% for AVR, 95% for MVR and 84% for DVR. No mortality due to heamorrhagic events was observed. CarboMedics prosthetic heart valves may be used satisfactorily with a low incidence of valve-related morbidity and mortality. | lld:pubmed |
pubmed-article:10637388 | pubmed:language | eng | lld:pubmed |
pubmed-article:10637388 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10637388 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10637388 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10637388 | pubmed:month | Dec | lld:pubmed |
pubmed-article:10637388 | pubmed:issn | 1341-1098 | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:SonculHH | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:SinciVV | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:KalayciogluSS | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:GokgozLL | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:HalinPP | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:GunaydinSS | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:ImrenYY | lld:pubmed |
pubmed-article:10637388 | pubmed:author | pubmed-author:EesozAA | lld:pubmed |
pubmed-article:10637388 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10637388 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:10637388 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10637388 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10637388 | pubmed:pagination | 382-6 | lld:pubmed |
pubmed-article:10637388 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:meshHeading | pubmed-meshheading:10637388... | lld:pubmed |
pubmed-article:10637388 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10637388 | pubmed:articleTitle | Eight year experience with the CarboMedics bileaflet valvular prosthesis. | lld:pubmed |
pubmed-article:10637388 | pubmed:affiliation | Department of Thoracic and Cardiovascular Surgery, Gazi University School of Medicine, Ankara, Turkey. | lld:pubmed |
pubmed-article:10637388 | pubmed:publicationType | Journal Article | lld:pubmed |